Haemonetics gets FDA approval for expanded VASCADE MVP XL labeling

March 30, 2026 4:15 PM

Haemonetics Corporation (NYSE: HAE) received U.S. Food and Drug Administration approval to expand labeling for its VASCADE MVP XL venous ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found